Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. The company combines its cell expansion and cryopreservation platform with proprietary cell engineering technologies to build a pipeline of future cell therapies. Its lead NK cell therapy candidate, NKX019, uses NK cells collected from healthy donors.

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. The company is headquartered in South San Francisco, United States. Its lead NK cell therapy candidate, NKX019, uses NK cells collected from healthy donors.

1. 1Nkarta Inc. | Natural Killer Cell Therapy Autoimmune Carenkartatx.com
2. 2About Nkarta Disease-Modifying Therapies | Nkarta, Inc.nkartatx.com
3. 3Nkarta Therapeutics (United States)wikidata.org